![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | epigallocatechin gallate results in decreased expression of H1-5 mRNA | CTD | PMID:22079256 | (-)-epigallocatechin 3-gallate | increases expression | ISO | H1-5 (Homo sapiens) | 6480464 | epigallocatechin gallate results in increased expression of H1-5 protein | CTD | PMID:31195006 | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | H1-5 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of H1-5 mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | increases expression | ISO | H1f5 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of H1F5 mRNA | CTD | PMID:22206623 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of H1F5 protein | CTD | PMID:32145629 | 17beta-estradiol | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of H1-5 mRNA | CTD | PMID:31614463 | 2,2',4,4',5,5'-hexachlorobiphenyl | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:23146750 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | H1f5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of H1F5 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of H1F5 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | H1-5 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of H1-5 mRNA | CTD | PMID:22574217 | 3,3',5-triiodo-L-thyronine | increases expression | ISO | H1-5 (Homo sapiens) | 6480464 | Triiodothyronine results in increased expression of H1-5 mRNA | CTD | PMID:23397585 | 3-chloropropane-1,2-diol | increases expression | EXP | | 6480464 | alpha-Chlorohydrin results in increased expression of H1F5 protein | CTD | PMID:34915118 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | H1f5 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of H1F5 mRNA | CTD | PMID:18648102 | 6-propyl-2-thiouracil | affects expression | EXP | | 6480464 | Propylthiouracil affects the expression of H1F5 mRNA | CTD | PMID:24780913 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of H1F5 mRNA | CTD | PMID:31881176 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of H1F5 mRNA | CTD | PMID:28959563 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of H1F5 mRNA | CTD | PMID:25378103 | all-trans-retinoic acid | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of H1-5 mRNA | CTD | PMID:33167477 | benzo[a]pyrene | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of H1-5 mRNA | CTD | PMID:20064835 and PMID:22316170 | benzo[a]pyrene | decreases methylation | ISO | H1-5 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of H1-5 exon and Benzo(a)pyrene results in decreased methylation of H1-5 promoter | CTD | PMID:27901495 | benzo[b]fluoranthene | increases expression | ISO | H1f5 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of H1F5 mRNA | CTD | PMID:26377693 | bisphenol A | increases expression | ISO | H1f5 (Mus musculus) | 6480464 | bisphenol A results in increased expression of H1F5 mRNA | CTD | PMID:21932408 | bisphenol A | multiple interactions | ISO | H1-5 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of H1-5 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of H1-5 mRNA and bisphenol A results in decreased expression of H1-5 protein | CTD | PMID:29275510 and PMID:34186270 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of H1F5 mRNA | CTD | PMID:25181051 and PMID:34947998 | Bisphenol B | increases expression | ISO | H1-5 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of H1-5 protein | CTD | PMID:34186270 | bisphenol F | increases expression | ISO | H1-5 (Homo sapiens) | 6480464 | bisphenol F results in increased expression of H1-5 protein | CTD | PMID:34186270 | caffeine | increases expression | ISO | H1-5 (Homo sapiens) | 6480464 | Caffeine results in increased expression of H1-5 protein | CTD | PMID:31195006 | caffeine | decreases phosphorylation | ISO | H1-5 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of H1-5 protein | CTD | PMID:35688186 | calcitriol | multiple interactions | ISO | H1-5 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of H1-5 mRNA | CTD | PMID:21592394 | calcitriol | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of H1-5 mRNA | CTD | PMID:21592394 | cannabidiol | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | Cannabidiol results in decreased expression of H1-5 mRNA | CTD | PMID:33244087 | carbon nanotube | affects expression | ISO | H1f5 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chlormequat chloride | increases expression | EXP | | 6480464 | Chlormequat results in increased expression of H1-5 protein | CTD | PMID:34958886 | cisplatin | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of H1-5 mRNA | CTD | PMID:27594783 | cobalt dichloride | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of H1-5 mRNA | CTD | PMID:19320972 | copper atom | affects binding | ISO | H1-5 (Homo sapiens) | 6480464 | H1-5 protein binds to Copper | CTD | PMID:14534351 | copper(0) | affects binding | ISO | H1-5 (Homo sapiens) | 6480464 | H1-5 protein binds to Copper | CTD | PMID:14534351 | copper(II) sulfate | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of H1-5 mRNA | CTD | PMID:19549813 | coumarin | decreases phosphorylation | ISO | H1-5 (Homo sapiens) | 6480464 | coumarin results in decreased phosphorylation of H1-5 protein | CTD | PMID:35688186 | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of H1F5 mRNA | CTD | PMID:26577399 | deoxynivalenol | decreases phosphorylation | ISO | H1f5 (Mus musculus) | 6480464 | deoxynivalenol results in decreased phosphorylation of H1F5 protein | CTD | PMID:23352502 | dibenz[a,h]anthracene | increases expression | ISO | H1f5 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:26377693 | dichloroacetic acid | increases expression | ISO | H1f5 (Mus musculus) | 6480464 | Dichloroacetic Acid results in increased expression of H1F5 mRNA | CTD | PMID:28962523 | dimethylarsinous acid | increases expression | ISO | H1-5 (Homo sapiens) | 6480464 | dimethylarsinous acid results in increased expression of H1-5 mRNA | CTD | PMID:23876855 | dioxygen | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of H1-5 mRNA | CTD | PMID:26516004 | dopamine | increases expression | ISO | H1-5 (Homo sapiens) | 6480464 | Dopamine results in increased expression of H1-5 protein | CTD | PMID:24675778 | doxorubicin | affects expression | ISO | H1-5 (Homo sapiens) | 6480464 | Doxorubicin affects the expression of H1-5 mRNA | CTD | PMID:29803840 | doxorubicin | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of H1-5 mRNA | CTD | PMID:30031762 | folic acid | multiple interactions | ISO | H1-5 (Homo sapiens) | 6480464 | [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of H1-5 mRNA | CTD | PMID:24657277 | folic acid | decreases expression | ISO | H1f5 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of H1F5 mRNA | CTD | PMID:25629700 | fulvestrant | multiple interactions | ISO | H1-5 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of H1-5 gene | CTD | PMID:31601247 | genistein | multiple interactions | ISO | H1-5 (Homo sapiens) | 6480464 | ESR2 promotes the reaction [Genistein results in increased expression of H1-5 protein] | CTD | PMID:20884965 | genistein | increases expression | ISO | H1-5 (Homo sapiens) | 6480464 | Genistein results in increased expression of H1-5 protein | CTD | PMID:20884965 | glycidol | decreases expression | EXP | | 6480464 | glycidol results in decreased expression of H1F5 mRNA | CTD | PMID:24395379 | hydrogen peroxide | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | Hydrogen Peroxide results in decreased expression of H1-5 mRNA | CTD | PMID:34581912 | hydroquinone | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | hydroquinone results in decreased expression of H1-5 mRNA | CTD | PMID:23416264 | lipopolysaccharide | multiple interactions | ISO | H1-5 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of H1-5 mRNA | CTD | PMID:35811015 | lucanthone | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | Lucanthone results in decreased expression of H1-5 mRNA | CTD | PMID:21148553 | menadione | affects expression | ISO | H1-5 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of H1-5 mRNA | CTD | PMID:20044591 | methotrexate | multiple interactions | ISO | H1-5 (Homo sapiens) | 6480464 | [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of H1-5 mRNA | CTD | PMID:24657277 | methotrexate | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | Methotrexate results in decreased expression of H1-5 mRNA | CTD | PMID:24657277 | methylisothiazolinone | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | 2-methyl-4-isothiazolin-3-one results in decreased expression of H1-5 mRNA | CTD | PMID:31629900 | N-methyl-4-phenylpyridinium | increases expression | ISO | H1-5 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of H1-5 protein | CTD | PMID:24675778 | N-methyl-4-phenylpyridinium | increases expression | ISO | H1f5 (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of H1F5 protein | CTD | PMID:26558463 | N-Nitrosopyrrolidine | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | N-Nitrosopyrrolidine results in decreased expression of H1-5 mRNA | CTD | PMID:32234424 | nobiletin | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | nobiletin results in decreased expression of H1-5 mRNA | CTD | PMID:23321314 | nobiletin | decreases expression | EXP | | 6480464 | nobiletin results in decreased expression of H1F5 mRNA | CTD | PMID:23321314 | phenobarbital | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | Phenobarbital results in decreased expression of H1-5 mRNA | CTD | PMID:19084549 | picene | increases expression | ISO | H1-5 (Homo sapiens) | 6480464 | picene results in increased expression of H1-5 mRNA | CTD | PMID:32251684 | potassium chromate | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of H1-5 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | H1-5 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of H1-5 mRNA | CTD | PMID:22079256 | progesterone | decreases expression | ISO | H1f5 (Mus musculus) | 6480464 | Progesterone results in decreased expression of H1F5 mRNA | CTD | PMID:22238285 | quercetin | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of H1-5 mRNA | CTD | PMID:30152185 | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of H1F5 mRNA | CTD | PMID:28374803 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | H1-5 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of H1-5 mRNA | CTD | PMID:35811015 | silicon dioxide | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of H1-5 mRNA | CTD | PMID:25895662 | silver(1+) nitrate | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | Silver Nitrate analog results in decreased expression of H1-5 mRNA and Silver Nitrate results in decreased expression of H1-5 mRNA | CTD | PMID:22831968 | sodium arsenite | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of H1-5 mRNA | CTD | PMID:23876855 and PMID:24516582 | sodium arsenite | increases expression | ISO | H1-5 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of H1-5 mRNA | CTD | PMID:29301061 | sunitinib | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of H1-5 mRNA | CTD | PMID:31533062 | testosterone | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of H1-5 mRNA | CTD | PMID:21592394 | testosterone | multiple interactions | ISO | H1-5 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of H1-5 mRNA | CTD | PMID:21592394 | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of H1F5 mRNA | CTD | PMID:30012374 | titanium dioxide | increases expression | ISO | H1f5 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of H1F5 mRNA | CTD | PMID:29264374 | trichloroethene | increases expression | ISO | H1f5 (Mus musculus) | 6480464 | Trichloroethylene results in increased expression of H1F5 mRNA | CTD | PMID:25549359 | trimellitic anhydride | increases expression | ISO | H1f5 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of H1F5 mRNA | CTD | PMID:19042947 | triptonide | decreases expression | ISO | H1f5 (Mus musculus) | 6480464 | triptonide results in decreased expression of H1F5 mRNA | CTD | PMID:33045310 | trovafloxacin | decreases expression | ISO | H1f5 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of H1F5 mRNA | CTD | PMID:35537566 | versicolorin A | decreases expression | ISO | H1-5 (Homo sapiens) | 6480464 | versicolorin A results in decreased expression of H1-5 mRNA | CTD | PMID:32106047 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of H1F5 mRNA | CTD | PMID:23034163 | |